These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 372883)

  • 1. [Effect of alpha methyldopa on the mixed oxygenase system of the liver in man].
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Orv Hetil; 1979 Apr; 120(15):897-8. PubMed ID: 372883
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of alpha-methyldopa and a new enzyme inducer, Zixoryn, on the hepatic mixed-function monooxygenase system in humans.
    Gachályi B; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):183-5. PubMed ID: 6862721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a non-steroid anti-inflammatory agent on the drug metabolizing activity of the human liver.
    Gachályi B; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):353-4. PubMed ID: 6469424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
    Larousse C; Kergueris MF; Le Normand Y; Visset J
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mono-oxygenase enzyme system of the liver in patients with true eczema].
    Ashirmetov AKh; Akovbian VA; Krakovskiĭ ME; Tikhonova NN
    Vestn Dermatol Venerol; 1990; (4):46-9. PubMed ID: 2143879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable inhibition of human hepatic drug metabolizing enzymes by disulfiram.
    Freundt KJ
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):323-30. PubMed ID: 669879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and environmental factors affecting drug response in man.
    Vesell ES
    Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
    [No Abstract]   [Full Text] [Related]  

  • 10. [The mono-oxygenase enzyme system of the liver in patients with viral hepatitis A and B].
    Musabaev EI; Krakovskiĭ ME; Ashirmetov AKh
    Klin Med (Mosk); 1987 Sep; 65(9):79-82. PubMed ID: 3695318
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of a new compound (m-trifluormethyl-alpha-ethylbenxhydrol) on the mixed oxygenase function system of the liver].
    Gachályi B; Káldor A; Szeberényi S
    Orv Hetil; 1979 Jan; 120(1):16-8. PubMed ID: 760033
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of hepatic enzyme inducing effect of sodium valproate.
    Oxley J; Hedges A; Makki KA; Monks A; Richens A
    Br J Clin Pharmacol; 1979 Aug; 8(2):189-90. PubMed ID: 385027
    [No Abstract]   [Full Text] [Related]  

  • 13. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of alpha methyldopa and phenobarbital on angiotensin sensitivity and renin activity in man].
    Káldor A; Gachályi B; Kállay K; Fekete S; Földvári A
    Orv Hetil; 1975 Jan; 116(1):9-11. PubMed ID: 1088983
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Trifluoromethyl-alpha-ethylbenzhydrol (RGH-3332). Liver enzyme induction and D-glucaric acid excretion.
    Váradi A
    Arzneimittelforschung; 1978; 28(4):678-9. PubMed ID: 581947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
    Malaka-Zafiriu K; Koliouskas D; Kontopoulos E; Danielides B; Cassimos C
    Helv Paediatr Acta; 1981; 36(2):149-58. PubMed ID: 6114077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The features of hepatic enzyme induction with glutethimide in man.
    Jackson L; Homeida M; Roberts CJ
    Br J Clin Pharmacol; 1978 Dec; 6(6):525-8. PubMed ID: 728322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
    Traeger A; Horváth T; Rechenbach C; Jávor T
    Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.